Syndax Pharmaceuticals, Inc.
SNDX
$16.24
$0.402.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 468.71M | 516.31M | 582.91M | 406.40M | 432.27M |
| Total Receivables | 37.42M | 21.48M | 13.87M | 4.69M | 10.88M |
| Inventory | 17.70M | 7.37M | 366.00K | -- | -- |
| Prepaid Expenses | 6.38M | 3.05M | 5.30M | 3.51M | 2.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.47M | 538.00K | 612.00K | 218.00K | 62.00K |
| Total Current Assets | 531.68M | 548.75M | 603.06M | 414.81M | 446.06M |
|
|
|||||
| Total Current Assets | 531.68M | 548.75M | 603.06M | 414.81M | 446.06M |
| Net Property, Plant & Equipment | 1.63M | 1.80M | 2.02M | 756.00K | 1.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 217.00K | 217.00K | 217.00K | 217.00K | 373.00K |
| Total Assets | 596.15M | 640.71M | 724.82M | 425.81M | 476.95M |
|
|
|||||
| Total Accounts Payable | 17.35M | 10.05M | 11.63M | 4.90M | 11.57M |
| Total Accrued Expenses | 75.23M | 57.21M | 59.68M | 47.91M | 26.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.79M | 14.53M | 12.60M | 852.00K | 993.00K |
| Total Finance Division Other Current Liabilities | 618.00K | 12.76M | 19.65M | 5.71M | 3.32M |
| Total Other Current Liabilities | 618.00K | 12.76M | 19.65M | 5.71M | 3.32M |
| Total Current Liabilities | 112.99M | 94.55M | 103.55M | 59.38M | 42.47M |
|
|
|||||
| Total Current Liabilities | 112.99M | 94.55M | 103.55M | 59.38M | 42.47M |
| Long-Term Debt | 324.41M | 329.64M | 331.57M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.33M | 1.45M | 1.58M | 2.00K | 137.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 438.73M | 425.65M | 436.69M | 59.38M | 42.61M |
|
|
|||||
| Common Stock & APIC | 1.53B | 1.52B | 1.51B | 1.49B | 1.48B |
| Retained Earnings | -1.38B | -1.31B | -1.22B | -1.13B | -1.04B |
| Treasury Stock & Other | 285.00K | 527.00K | 163.00K | 371.00K | -817.00K |
| Total Common Equity | 157.42M | 215.06M | 288.12M | 366.43M | 434.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 157.42M | 215.06M | 288.12M | 366.43M | 434.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 157.42M | 215.06M | 288.12M | 366.43M | 434.34M |
|
|
|||||